Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hypochlorous Company is a biotechnology firm specializing in the development and commercialization of stabilized hypochlorous acid (HOCl) solutions for medical and consumer use. The company leverages the natural antimicrobial properties of HOCl, a molecule produced by the human immune system, to create non-toxic, highly effective treatments for wound care, dermatology, and infection control. Their product portfolio includes advanced wound cleansers, skin soothing sprays, and ophthalmic solutions designed to eliminate pathogens without damaging healthy tissue. By overcoming the historical stability challenges of HOCl, the company provides a sustainable and biocompatible alternative to traditional antibiotics and harsh chemical disinfectants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Hypochlorous Company.